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Abstract 
Short communication on t(2;8)(p23;p11) 
KAT6A/ASXL2, with data on clinics, and the 
genes implicated. 
Clinics and pathology 
Disease 
Treatment-related myelodysplastic syndrome (t-
MDS) 
Epidemiology 
Only one case to date, a 6-year old girl who have 
had a M2 acute myeloid leukemia (M2-AML) with 
a t(8;21)(q22;q22), treated with 
epipodophyllotoxin, 17 months before onset of a 
therapy related myelodysplasia.  
She died 14 months after diagnosis of the t-MDS 
(Imamura et al., 2003). 






Polycomb-group (PcG) and trithorax-group (trxG) 
proteins regulate histone methylation to establish 
repressive and active chromatin configurations in 
Drosophila.  
Mutations in Asx (the homolog of ASXL2) enhance 
both Polycomb-group (PcG) and trithorax-group  
 
 
(trxG) mutant phenotypes (Baskind et al., 2009). 
ASXL2 is an enhancer of PcG activity.  
ASXL2 and the histone methyltansferase EZH2 
(7q36) directly represses MYH7 (14q11) (Beta-
Myosin Heavy Chain) (Lai et al., 2012).  
ASXL2 is implicated in prostate, breast, pancreatic 
cancers (review in Katoh, 2013).  
EPC1-ASXL2 fusion gene has been found in adult 
T-cell leukaemia/lymphoma with a 
t(2;10)(p23;p11) (Nakahata et al., 2009).  






KAT6A is also known as MYST3, or MOZ. 
Protein 
KAT6A is a histone acetyltransferase (HAT). 
KAT6A has intrinsic HAT activity; KAT6A also 
forms complexes with MEAF6 (1p34), ING5 
(2q37), and BRPF1 (3p25) to acetylate histones H3. 
KAT6A is a transcriptional co-activator; it interacts 
with RUNX1 (21q22) and SPI1/PU.1 (11p11) to 
regulate the expression of haematopoietic-related 
genes; KAT6A and MLL (11q23), an histone 
methyltransferase, cooperate to regulate HOX 
genes, which are key genes in human cord blood 
CD34+ cells progenitors, and are critical for 
leukemogenesis.  
KAT6A is also an epigenetic regulator of 
haematopoiesis (reviews in Perez-Campo et al., 
2013; Yang and Ullah, 2007). 
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Exons 2-13 of ASXL2 are fused to exons 1-14 of 
the KAT6A (Katoh and Katoh, 2004). 
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